期刊文献+

乳腺癌中TSG101与MAPK/ERK信号通路的关系 被引量:3

Relationship between TSG101 and MAPK/ERK signal pathway in breast cancer
下载PDF
导出
摘要 目的研究乳腺癌中TSG101与MAPK/ERK信号通路的关系。方法应用脂质体法将靶向TSG101的siRNA转染入乳腺癌细胞株MCF-7中。分别使用免疫荧光和Western blot方法检测siRNA干扰后MCF-7中p-ERK蛋白表达的改变。使用免疫组织化学方法检测TSG101、p-ERK蛋白在54例人乳腺癌组织中的表达。结果 TSG101 siRNA转染后的MCF-7中p-ERK蛋白表达明显减少。TSG101和p-ERK蛋白在乳腺癌组织中的阳性率分别为74.07%、81.48%。TSG101和p-ERK在乳腺癌组织中的蛋白表达存在正相关(r=0.371,P<0.05)。结论 TSG101在乳腺癌中可能通过MAPK/ERK信号通路发挥生物学作用。 Objective To investigate the relation between TSG101 and MAPK/ERK signal pathway in breast cancer. Methods TSG101 siRNA were transfected into breast cancer MCF-7 cell line via lipofection. The protein expressions of p- ERK in MCF-7 cells before and after transfection were assessed by and Western blot. Immtmohistochemical method was adopted to detect the expressions of TSG101 and p-ERK proteins in 54 cases of human breast cancer tissues. Results The expression of p-ERK protein was reduced significantly after TSG101 siRNA transfection than before. The positive expression rate of TSG101 and p-ERK was 74.07% and 81.48% separately in invasive duetal carcinoma of breast. The correlation between the expressions of TSG101 and p-ERK in breast cancer were significant. Conclusions The correlation between the expressions of TSG101 and p-ERK in breast cancer cells and tissues were significant. TSG101 may play biology effect through MAPK/ERK signal pathway in breast cancer.
出处 《山东医药》 CAS 北大核心 2011年第1期18-20,共3页 Shandong Medical Journal
基金 辽宁省高等学校科研项目(2008739)
关键词 乳腺肿瘤 TSG101 SIRNA MAPK/ERK breast neoplasms TSG101 siRNA MAPK/ERK
  • 相关文献

参考文献7

  • 1Li L,Cohen SN.TSG101:a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells[J].Cell,1996,85(3):319-329.
  • 2Aebersold DM,Burri P,Beer K,et al.Expression of hypoxia-inducible factor-1alpha:a novel predictive and prognostic parameter in theradiotherapy of oropharyngeal cancer[J].Cancer Res,2004,61(7):2911-2916.
  • 3龚西騟.WHO乳腺肿瘤组织学分类(2003)简介[J].临床与实验病理学杂志,2004,20(1):5-10. 被引量:35
  • 4申慧琴,韩者艺,薛妍,郭长存,扎西措姆,韩霜,程翌,胡家露,樊代明.肿瘤易感基因101在胃癌耐药细胞中的表达及作用[J].中华消化杂志,2004,24(9):515-518. 被引量:7
  • 5许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1366
  • 6Ebisuya M,Kondon K,Nishida E.The duration magnitude and compartmentalization of ERK MAPk kinase activity:mechanisms of providing signaling specificity[J].J Cell Sci,2005,118(pt 14):2997-3002.
  • 7Oh KB,Stanton MJ,West WW,et al.Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation[J].Oncogene,2007,26(40):5950-5959.

二级参考文献13

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3[1]Tavassoli FA, Devilee P. WHO classification of tumours. Pathology & genetics, tumours of the breast and female genital organs. Lyon: IARC Press,2003.
  • 4[2]World Health Organization:Histological typing of breast tumors. 2nd ed, International histological classification of tumors. Genera:World Health Organization, 1981.
  • 5Oh H,Mammucari C,Nenci A,et al.Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1[].Proceedings of the National Academy of Sciences of the United States of America.2002
  • 6Ruland J,Sirard C,Eia A,et al.p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking TSG101[].Proceedings of the National Academy of Sciences of the United States of America.2001
  • 7Zhao Y,You H,Liu F,et al.Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells[].Cancer Letters.2002
  • 8Shi Y,Han Y,Wang X,et al.MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells[].Gastric Cancer.2002
  • 9Krempler A,Henry MD,Triplett AA,et al.Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1 /S and p53-independent cell death[].Journal of Biological Chemistry.2002
  • 10Wagner KU,Krempler A,Qi Y,et al.TSG101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues[].Molecular and Cellular Biology.2003

共引文献1401

同被引文献53

  • 1宗永生,吴秋良,林素暇,何洁华,张昌卿.EB病毒相关性疾病病理学研究的进展[J].中山大学学报(医学科学版),2005,26(5):481-487. 被引量:27
  • 2Tang CH,Tsai CC. CCL2 increases MMP-9 expression and cell motil- ity in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF- KB signaling pathway [J]. Biochem Pharmacol, 2012,83 (3) : 335-344.
  • 3Chang F,Steelman I~,Shelton JG,et al. Regulation of cell cycle pro- gression and apoptosis by the Ras/Raf/MEK/ERK pathway [J]. Int J Oncol, 2003,22 ( 3 ) : 469-480.
  • 4Lee SJ, Namkoong S, Kim YM, et al. Fractalkine stimulates angiogen- esis by activating the Raf-1/MEK/ERK-and PI3K/Akt/eNOS-depen- dent signal pathways [J]. Am J Physiol Heart Circ Physiol,2006,291 (6) : 2836-2846.
  • 5Leelahavanichkul K,Amornphimoltham P, Molinolo AA, et al. A role for p38 MAPK in head and neck cancer cell growth and tumor-in- duce dangiogenesis and lymphangiogenesis [J]. Molecular Ontology, 2014,8(1 ) :105-118.
  • 6Salinas-S6nchez AS,Gim~nez-Bachs JM,Serrano-OviedoL,et al. Role of mitogen-activated proteinkinase (MAPK)in the sporadicre- hal cell carcinoma [J]. Actas Urol Esp,2012,36(2):99-103.
  • 7Zhang Y,Jiang X,Qin X,et al. RKTG inhibit sangiogenesis by sup- pressing MAPK-mediated autocrine VEGF signaling and is down- regulated in clear-ceU renal cell carcinoma [J]. Oncogene,2010,29 (39) :5404-5415.
  • 8Zhan YH,Liu J,Qu XJ,et al. 13-Elemene induces apoptosis in hu- man renal-cell carcinoma 786-0cells through inhibition of MAPK/ ERKandPI3K/Akt/mTOR signalling pathways [J]. Asian Pac J Can- cer Prev,2012,13(6) :2739-2744.
  • 9Komi Y,Sogabe Y,Ishibashi N,et al. Acyclic retinoid inhibits an- giogenesis by suppressing the MAPK pathway [J]. Lab Invest,2010, 90( 1 ) :52-60.
  • 10Steffel J,Amet C ,Akhmedov A ,et al. Histamine differentially inter- acts with tumor necrosis factor-alpha and thrombinin endothelial tissue factor induction:the role of c-Jun NH2-terminal kinase [J]. J Thromb Haemost, 2006,4 ( 11 ) : 2452-2460.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部